| |
| |
|
| Insider
Information: |
Kaye Jack |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
146,280 |
|
|
Indirect Shares
|
1,400 |
|
|
| Direct
Value |
$177,929 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
147,680 |
|
|
| Total
Value |
$177,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -96.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2015-06-17 |
85,000 |
2007-06-19 |
1,400 |
Premium* |
|
|
uniQure B.V. |
QURE |
Director |
2023-02-27 |
27,699 |
2018-01-26 |
0 |
Premium* |
|
|
Dyadic International Inc |
DYAI |
Director |
2024-01-03 |
33,581 |
2024-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYAI |
Dyadic International Inc |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
33,581 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2023-02-27 |
4 |
S |
$19.99 |
$7,676 |
D/D |
(384) |
27,699 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,080 |
28,083 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2022-02-28 |
4 |
S |
$16.76 |
$10,056 |
D/D |
(600) |
19,003 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,534 |
19,603 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2021-03-02 |
4 |
S |
$37.60 |
$18,950 |
D/D |
(504) |
18,069 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,382 |
18,573 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,063 |
16,191 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2020-01-28 |
4 |
S |
$62.20 |
$50,133 |
D/D |
(806) |
14,128 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-01-28 |
4 |
S |
$31.31 |
$37,885 |
D/D |
(1,210) |
14,934 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,230 |
16,144 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2018-01-29 |
4 |
S |
$18.53 |
$53,329 |
D/D |
(2,878) |
12,914 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,792 |
15,792 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2015-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
85,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2014-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
75,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2013-09-06 |
4 |
GD |
$9.13 |
$136,950 |
D/D |
15,000 |
65,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
80,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-06-27 |
4 |
GD |
$1.81 |
$18,100 |
D/D |
10,000 |
65,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
75,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-01-03 |
4 |
GD |
$2.65 |
$25,758 |
D/D |
9,720 |
60,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2011-12-15 |
4 |
GD |
$2.42 |
$209,766 |
D/D |
86,680 |
69,720 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2011-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
156,400 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2010-12-06 |
4 |
S |
$5.00 |
$100,000 |
D/D |
(20,000) |
141,400 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2010-09-29 |
4 |
S |
$5.02 |
$125,500 |
D/D |
(25,000) |
161,400 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2010-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
186,400 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
